Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denis M Tebit

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
AIDS Research and Therapy|July 29, 2017
High level of HIV-1 drug resistance mutations in patients with unsuppressed viral loads in rural northern South AfricaElizabeth M Etta, Lufuno Mavhandu, Cecile Manhaeve, et al.
The Journal of Antimicrobial Chemotherapy|August 28, 2009
Mutation T74S in HIV-1 subtype B and C proteases resensitizes them to ritonavir and indinavir and confers fitness advantageEsmeralda A Soares, André F Santos, Luis M Gonzalez, et al.
Plos One|April 15, 2014
Similar replicative fitness is shared by the subtype B and unique BF recombinant HIV-1 isolates that dominate the epidemic in ArgentinaAndrea E Rubio, Awet Abraha, Crystal A Carpenter, et al.
Journal of Medical Virology|March 24, 2006
Seroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso: A comparative analysisEllen Collenberg, Thierry Ouedraogo, Jean Ganamé, et al.
AIDS (London, England)|June 4, 2013
Treatment failure and drug resistance is more frequent in HIV-1 subtype D versus subtype A-infected Ugandans over a 10-year study periodFred Kyeyune, Immaculate Nankya, Samar Metha, et al.
The Open AIDS Journal|June 26, 2009
Cross-clade recognition of HIV-1 CAp24 by CD4+ T cells in HIV-1-infected individuals in Burkina Faso and GermanyThomas Böhler, Vanessa Mrosek, Kerstin Müller, et al.
Journal of Virology|August 31, 2007
Evolution of human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitopes: fitness-balanced escapeYi Liu, John McNevin, Hong Zhao, et al.
Plos One|September 13, 2022
COVID-19 vaccine acceptance and perceived risk among pregnant and non-pregnant adults in Cameroon, AfricaNuwan Gunawardhana, Kendall Baecher, Alexander Boutwell, et al.
Journal of Virology|March 20, 2009
CCR5- and CXCR4-tropic subtype C human immunodeficiency virus type 1 isolates have a lower level of pathogenic fitness than other dominant group M subtypes: implications for the epidemicAwet Abraha, Immaculate L Nankya, Richard Gibson, et al.
Plos One|April 10, 2014
Impact of mutations in highly conserved amino acids of the HIV-1 Gag-p24 and Env-gp120 proteins on viral replication in different genetic backgroundsYi Liu, Ushnal Rao, Jan McClure, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
AIDS Research and Therapy|July 29, 2017
High level of HIV-1 drug resistance mutations in patients with unsuppressed viral loads in rural northern South AfricaElizabeth M Etta, Lufuno Mavhandu, Cecile Manhaeve, et al.
The Journal of Antimicrobial Chemotherapy|August 28, 2009
Mutation T74S in HIV-1 subtype B and C proteases resensitizes them to ritonavir and indinavir and confers fitness advantageEsmeralda A Soares, André F Santos, Luis M Gonzalez, et al.
Plos One|April 15, 2014
Similar replicative fitness is shared by the subtype B and unique BF recombinant HIV-1 isolates that dominate the epidemic in ArgentinaAndrea E Rubio, Awet Abraha, Crystal A Carpenter, et al.
Journal of Medical Virology|March 24, 2006
Seroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso: A comparative analysisEllen Collenberg, Thierry Ouedraogo, Jean Ganamé, et al.
AIDS (London, England)|June 4, 2013
Treatment failure and drug resistance is more frequent in HIV-1 subtype D versus subtype A-infected Ugandans over a 10-year study periodFred Kyeyune, Immaculate Nankya, Samar Metha, et al.
The Open AIDS Journal|June 26, 2009
Cross-clade recognition of HIV-1 CAp24 by CD4+ T cells in HIV-1-infected individuals in Burkina Faso and GermanyThomas Böhler, Vanessa Mrosek, Kerstin Müller, et al.
Journal of Virology|August 31, 2007
Evolution of human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitopes: fitness-balanced escapeYi Liu, John McNevin, Hong Zhao, et al.
Plos One|September 13, 2022
COVID-19 vaccine acceptance and perceived risk among pregnant and non-pregnant adults in Cameroon, AfricaNuwan Gunawardhana, Kendall Baecher, Alexander Boutwell, et al.
Journal of Virology|March 20, 2009
CCR5- and CXCR4-tropic subtype C human immunodeficiency virus type 1 isolates have a lower level of pathogenic fitness than other dominant group M subtypes: implications for the epidemicAwet Abraha, Immaculate L Nankya, Richard Gibson, et al.
Plos One|April 10, 2014
Impact of mutations in highly conserved amino acids of the HIV-1 Gag-p24 and Env-gp120 proteins on viral replication in different genetic backgroundsYi Liu, Ushnal Rao, Jan McClure, et al.
Pageof 4